Dr. Eric Chen, MD

Dr. Chen practices at Retina Consultants of Houston in Bellaire, Texas.

Dr. Chen's NPI, 1578521779, was assigned on May 4, 2006. Dr. Chen graduated from Baylor College Of Medicine in 2001. Dr. Chen holds Texas license M6563.

Dr. Chen's primary practice is Retina Consultants of Houston, at 6300 W S Loop, Bellaire, TX 77401 in Harris County. The practice phone is (713) 524-3434.

Dr. Chen's primary practice is Retina Consultants of Houston in Bellaire, Texas. Dmand AI also links Dr. Chen to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Chen is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chen's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists age-related macular degeneration, cold sores or genital herpes, dry eye, eyelid inflammation, glaucoma, hereditary corneal conditions, hypertensive retinopathy and inflammation of iris among the conditions Dr. Chen treats.

CMS data shows 22,118 Medicare services from Dr. Chen across 19 procedure codes in 2024, for 933 Medicare patients. Medicare paid $2,917,329 for them. Every service was in an office.

CMS counts 933 Medicare patients who saw Dr. Chen in 2024. The largest group is 65 to 74, with 433 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 69, with 54% women.

In 2024, Dr. Chen wrote 296 Medicare Part D claims for 125 patients. 58% of them were for generic drugs. CMS names the drug for 249 of them, across 8 drugs with 11 or more claims each, at $11,466 in total drug cost. In 2023, CMS named 259 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 25 papers to Dr. Chen, published from 2012 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Angiogenesis Inhibitors, Intravitreal Injections and Vascular Endothelial Growth Factor A. Dr. Chen has published most often in Retina. Dr. Chen's most frequent co-authors are David M. Brown, MD, James Calder Major, MD and Charles Clifton Wykoff, MD, PhD.

Dmand AI links Dr. Chen to 2 clinical trials. Conditions studied include Macular Edema and Macular Degeneration.

CMS Open Payments shows 151 general payments to Dr. Chen from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $1,568.

Dmand AI lists 1 award for Dr. Chen.

Dr. Chen graduated from Baylor College Of Medicine in 2001. Dr. Chen is a member of AAO.

Dr. Chen is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.